Associated Papers
SOX7 suppresses endothelial-to-mesenchymal transitions by enhancing VE-cadherin expression during outflow tract development.
Jiang X et al.
Clinical Science (london, England : 1979), 2021
Pharmacokinetic impact of SLCO1A2 polymorphisms on imatinib disposition in patients with chronic myeloid leukemia.
Yamakawa Y et al.
Clinical Pharmacology and Therapeutics, 2011
Select a paper to view details